Sarcoma News

The FDA granted fast track designation to tazemetostat for the treatment of patients with diffuse large B-cell lymphoma with EZH2 activating mutations, according to the drug’s manufacturer.

Having a child diagnosed with cancer significantly impacted parents’ income and often led to mothers ending their employment, according to a matched control cohort study conducted in Sweden.

Long-term, treatment-related health conditions in adult survivors of childhood cancers led to high rates of emotional distress, according to the results of a retrospective study.

Rates of high-intensity end-of-life care have remained high among children with cancer, especially those with hematologic malignancies, according to a retrospective analysis conducted in Ontario, Canada.

The TAPUR trial, the first clinical trial launched by ASCO, is underway at 38 centers in five states.

The launch of the Watson for Genomics sequencing service has the potential to bring precision medicine to cancer treatment centers worldwide, according to a press release issued by IBM Watson Health and Quest Diagnostics.

Patients with advanced cancer should receive dedicated, early palliative care concurrently with standard oncology treatment, according to ASCO’s updated guidelines published in Journal of Clinical Oncology.

The addition of palifosfamide to doxorubicin did not improve PFS in patients with metastatic soft tissue sarcoma, according to results of the randomized controlled phase 3 PICASSO III trial.

Patients with cancer may have an increased risk for treatment-related and -unrelated injuries in the periods preceding and following their cancer diagnosis, according to the results of a registry study conducted in Sweden.

Dasatinib monotherapy did not control sarcoma growth for at least 6 months in most patients with rare sarcomas, according to the results of a phase 2 study.